Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules
-
PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules
-
SOS Limited (SOS) Prices $25M Offering of ADSs and Warrants
-
SOS Ltd. Announces Pricing of Approximately $25.0 Million Registered Direct Offering
-
Castor Maritime Inc. (CTRM) Announces Pricing of $26 Million Registered Direct Offering of Common Shares, Warrants
-
Castor Maritime Inc. Announces Pricing of $26.0 Million Registered Direct Offering
-
BioNano Genomics, Inc. (BNGO) Prices 29M Share Common Stock Offering at $3.05/sh
-
Bionano Genomics Announces Pricing of $88.5 Million Underwritten Public Offering of Common Stock
-
BioNano Genomics, Inc. (BNGO) to Offer Common Stock
-
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock
-
Vickers Vantage Corp. I (VCKA) Prices 12M Unit IPO at $10/Unit
-
Vickers Vantage Corp. I Announces Pricing of Upsized $120,000,000 Initial Public Offering
-
PAVmed (PAVM) Announces Registered Direct Offering of its Common Stock
-
PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
-
PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
-
Atossa Therapeutics (ATOS) Prices $25.2M Registered Direct Offering Priced At-The-Market
-
Atossa Therapeutics Announces Pricing of $25.2 Million Registered Direct Offering Priced At-The-Market
-
MEDIROM Healthcare Technologies Inc. Announces Closing of $12,000,000 Initial Public Offering
-
Castor Maritime Inc. (CTRM) Prices $18M Registered Direct Offering
-
Castor Maritime Inc. Announces Pricing of $18.0 Million Registered Direct Offering
-
Customers Bancorp Listed in Kiplinger’s 6 Best Financial Stocks to Buy in 2021
-
MEDIROM Healthcare (MRM) IPO Opens 32% Higher
-
KULR Technology Group Announces Pricing of $8.0 Million Offering
-
Beam Global (BEEM) PT Raised to $90 at Maxim Group
-
Merrimac Industries (MRM) Prices 800K ADS Upsized IPO at $15/ADS
-
MEDIROM Healthcare Technologies Inc. Announces Pricing of Upsized $12.0 Million Initial Public Offering and Listing on NASDAQ
-
Kubient Announces Closing of $20.7 Million Public Offering and Exercise of Overallotment Option
-
Cellectar Biosciences Announces Closing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
BioMedNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Featured in Equity Research Report
-
BioMedNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Closes $100M Underwritten Public Offering
-
Cellectar Biosciences (CLRB) Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
Kubient Inc. (KBNT) Prices 3.53M Share Common Offering at $5.10/Sh
-
Kubient Announces Pricing of Upsized $18.0 Million Public Offering of Common Stock
-
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
-
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
-
Cyclo Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Underwritten Public Offering
-
PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
-
PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
-
SOS Limited (SOS) Prices Approximately $4 million Registered Direct Offering of ADSs and Warrants
-
SOS Ltd. Announces Pricing of Approximately $4.0 million Registered Direct Offering
-
PAVmed (PAVM) Prices Additional $8.1 Million Common Stock Registered Direct Offering
-
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
-
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
-
Blue Water Acquisition Corporation Announces Closing of $57.5 Million Initial Public Offering, Including Full Exercise of the Underwriter's Over-Allotment Option
-
Atossa Therapeutics (ATOS) Announces Pricing of $14 Million Registered Direct Offering of Common Stock, Warrants
-
Atossa Therapeutics Announces Pricing of $14.0 Million Registered Direct Offering Priced At-The-Market
-
Galapagos NV (GLPG:NA) (GLPG) PT Lowered to $140 at Maxim Group, Following Strategic Business Update
-
Bone Therapeutics announces closing of private placement
-
Blue Water Acquisition Corp. (BLUW) Prices 5M Unit IPO at $10/Unit

